berberine has been researched along with Cancer of Esophagus in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we treated esophageal cancer (EC) cell lines, TE1 and KYSE450 with coptisine (COP) and investigated the biological effects of COP in EC cells." | 1.62 | Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway. ( Chen, X; Liu, C; Qu, S; Wen, X; Yang, Y; Zhang, X, 2021) |
| "Treatment with galangin and berberine alone caused the decreased expressions of Wnt3a and β-catenin." | 1.43 | Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells. ( Han, X; Li, Z; Lu, H; Ren, J; Ren, K; Wu, G; Zhang, W, 2016) |
| "Berberine pretreatment led to a significant downregulation of RAD51, a key player in homologous recombination repair, in ESCC cells, but not in non-malignant human cells." | 1.37 | Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. ( Feng, S; Gong, Y; Guo, H; Hao, C; Jiang, H; Liu, Q; Liu, Z; Shao, C; Wang, Y; Xu, B; Yang, Q; Zhao, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, X | 1 |
| Zhang, X | 1 |
| Qu, S | 1 |
| Chen, X | 1 |
| Liu, C | 1 |
| Yang, Y | 1 |
| Yang, X | 1 |
| Yang, B | 1 |
| Cai, J | 1 |
| Zhang, C | 1 |
| Zhang, Q | 1 |
| Xu, L | 1 |
| Qin, Q | 1 |
| Zhu, H | 1 |
| Ma, J | 1 |
| Tao, G | 1 |
| Cheng, H | 1 |
| Sun, X | 1 |
| Ren, K | 1 |
| Zhang, W | 1 |
| Wu, G | 1 |
| Ren, J | 1 |
| Lu, H | 1 |
| Li, Z | 1 |
| Han, X | 1 |
| Liu, Q | 1 |
| Jiang, H | 1 |
| Liu, Z | 1 |
| Wang, Y | 1 |
| Zhao, M | 1 |
| Hao, C | 1 |
| Feng, S | 1 |
| Guo, H | 1 |
| Xu, B | 1 |
| Yang, Q | 1 |
| Gong, Y | 1 |
| Shao, C | 1 |
| Iizuka, N | 2 |
| Miyamoto, K | 2 |
| Okita, K | 2 |
| Tangoku, A | 2 |
| Hayashi, H | 1 |
| Yosino, S | 1 |
| Abe, T | 1 |
| Morioka, T | 1 |
| Hazama, S | 2 |
| Oka, M | 2 |
| Yoshino, S | 1 |
| Yoshimura, K | 1 |
| Fukumoto, T | 1 |
| Yamamoto, S | 1 |
6 other studies available for berberine and Cancer of Esophagus
| Article | Year |
|---|---|
Coptisine induces G2/M arrest in esophageal cancer cell via the inhibition of p38/ERK1/2/claudin-2 signaling pathway.
Topics: Antineoplastic Agents; Berberine; CDC2 Protein Kinase; Cell Line, Tumor; Cell Movement; Cell Prolife | 2021 |
Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo.
Topics: Animals; Apoptosis; Berberine; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Prolif | 2013 |
Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Berberine; beta Catenin; Carcino | 2016 |
Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51.
Topics: Berberine; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cells, Cult | 2011 |
Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines.
Topics: Antineoplastic Agents; Berberine; Cell Cycle; Cell Division; Coptis chinensis; Dose-Response Relatio | 2000 |
Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Berberin | 2000 |